U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. Science & Research
  3. About Science & Research at FDA
  4. FDA Grand Rounds
  5. FDA Grand Rounds - Salmonella and Escherichia coli: Challenges Along the One Health Continuum - 07/11/2024
  1. FDA Grand Rounds

Webcast | Virtual

Event Title
FDA Grand Rounds - Salmonella and Escherichia coli: Challenges Along the One Health Continuum
July 11, 2024

Date:
July 11, 2024
Time:
12:00 p.m. - 1:00 p.m. ET
Image
FDA Grand Rounds

About the Speaker

Steven Foley

Steven Foley, Ph.D.
Senior Biomedical Research and Biomedical Product Assessment Service (SBRBPAS) Expert and Director, Division of Microbiology
National Center for Toxicological Research (NCTR) 
Office of the Chief Scientist (OCS)
Office of the Commissioner (OC)

About the Speaker

Dr. Steven Foley is a Senior Biological Research and Biological Product Assessment Service (SBRBPAS) Expert and Director of the Division of Microbiology at FDA’s National Center for Toxicological Research (NCTR). Dr. Foley earned a Bachelor of Science degree in zoology and a Ph.D. in cellular and molecular biology/infectious diseases from North Dakota State University and completed a postdoctoral fellowship with FDA’s Center for Veterinary Medicine, where the focus of his research was on developing methods for source tracking of Salmonella from food-animal species.  At NCTR, Dr. Foley’s direct research team has been focused on the fields of zoonotic diseases, food safety, and the microbiology of FDA-regulated products.

About the Presentation

The presentation will focus on Salmonella and Escherichia coli which are bacterial pathogens that infects humans and a wide range of other animal hosts where they have the potential to spread to across species creating One Health concerns.  Many of these strains are also resistant to multiple antibiotics which leads to increased treatment challenges, making this antimicrobial resistance a significant public health concern.

Learning Objectives

  • Describe the importance of the One Health concept and how it applies to public health.
  • Discuss the importance of Salmonella enterica and Escherichia coli as One Health-related pathogens.
  • Discuss the challenges with antimicrobial resistance spread among Salmonella and E. coli.

Webcast Recording

https://fda.zoomgov.com/rec/share/D_9Znoe_MaPMRwgHV9DzNuE5QTmseCZ_UcC4ARJsbuMy4QAqLWxBe91_vfd85VH3.4U2riAQV5ajaEvye

Event Materials

Activity Outline - Continuing Education

For technical assistance please contact: Isaac.Miller@fda.hhs.gov
 

Back to Top